Is Rituximab an Acceptable Alternative to Ocrelizumab for Treating Multiple Sclerosis?
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rituximab Is an Acceptable Alternative to Ocrelizumab for Treating Multiple Sclerosis—Commentary
Mult. Scler. 2018 Feb 01;[EPub Ahead of Print], BAC CreeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.